Sean P. Nolan
Chief Executive Officer at Taysha Gene Therapies Inc.
Sits on 2 boards. Last updated September 28, 2026
Time on boards
- Boards served
- 2
- Current seats
- 2
- Board service
- 7 years
- Director since
- 2023
7 years of board service in total across 2 boards, counting each seat separately. Longest: Taysha Gene Therapies Inc., 3 years.
Chief executive roles
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Taysha Gene Therapies Inc. June 1, 202682.6%
-
Ventas Inc. May 12, 202698.0%
-
Ventas Inc. May 13, 202598.7%
-
Ventas Inc. May 14, 202491.1%
-
Taysha Gene Therapies Inc. June 22, 202390.1%
-
Ventas Inc. May 16, 202392.2%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| May 13, 2026 | Ventas Inc. | Grant or award | +2,047 | $90.35 | $184,946 |
| Jan 26, 2026 | Taysha Gene Therapies Inc. | Open-market sale | −41,312 | $4.61 | $190,448 |
| Jan 23, 2026 | Taysha Gene Therapies Inc. | Open-market sale | −136,789 | $4.75 | $649,748 |
| Jan 12, 2026 | Taysha Gene Therapies Inc. | Grant or award | +1,008,000 | — | — |
| May 13, 2025 | Ventas Inc. | Grant or award | +2,882 | $64.18 | $184,967 |
| Jan 2, 2025 | Taysha Gene Therapies Inc. | Grant or award | +892,500 | — | — |
| May 14, 2024 | Ventas Inc. | Grant or award | +3,648 | $47.96 | $174,958 |
| Jan 2, 2024 | Taysha Gene Therapies Inc. | Grant or award | +1,184,688 | — | — |
| Aug 16, 2023 | Taysha Gene Therapies Inc. | Open-market purchase | +444,444 | $0.90 | $400,000 |
| May 16, 2023 | Ventas Inc. | Grant or award | +3,835 | $45.63 | $174,991 |
| Jul 21, 2020 | Ventas Inc. | Open-market purchase | +27 | $34.21 | $924 |
| Jul 21, 2020 | Ventas Inc. | Open-market purchase | +37 | $34.21 | $1,266 |
| Apr 20, 2020 | Ventas Inc. | Open-market purchase | +36 | $27.70 | $997 |
| Apr 20, 2020 | Ventas Inc. | Open-market purchase | +50 | $27.70 | $1,385 |
Questions about Sean P. Nolan
What boards is Sean P. Nolan on?
Sean P. Nolan sits on the boards of Taysha Gene Therapies Inc. and Ventas Inc.
What company is Sean P. Nolan the CEO of?
Sean P. Nolan is Chief Executive Officer of Taysha Gene Therapies Inc.
How long has Sean P. Nolan served on boards?
Our records show at least 7 years of board service across 2 boards, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.